- Home
- About the University
- Find staff
- Anna Fager
Anna Fager
-
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid
exposure.
Maria Lindén, Hifaa Al Remawi, Anna Fager, Levent Akyürek, Anna Rudin, Lars Ny, Sara Bjursten, Ankur Pandita, Max Levin
Immunotherapy Advances - 2026 -
Evaluation of the flipped dose NIVO3+IPI1 in patients with advanced unresectable
melanoma
Karl Bjorkstrom, Cissi Liu, Anna Fager, Lisa L. Liu, Lars Ny, Hildur Helgadottir
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE - 2025 -
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain
metastases
Anna Fager, Matilda Samuelsson, Roger Olofsson Bagge, Aldina Pivodic, Sara Bjursten, Max Levin, Henrik Jespersen, Lars Ny
BJC REPORTS - 2025